Cargando…
Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19
Autor principal: | Ortiz-Martínez, Yeimer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194739/ https://www.ncbi.nlm.nih.gov/pubmed/32325121 http://dx.doi.org/10.1016/j.tmaid.2020.101678 |
Ejemplares similares
-
COVID19 therapeutics: Expanding the antiviral arsenal
por: Gallagher, Tom
Publicado: (2021) -
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
por: Bennardo, Francesco, et al.
Publicado: (2020) -
Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer
por: Lantier, Louis, et al.
Publicado: (2020) -
Probiotics in the Therapeutic Arsenal of Dermatologists
por: Navarro-López, Vicente, et al.
Publicado: (2021) -
RFX1: a promising therapeutic arsenal against cancer
por: Issac, Joby, et al.
Publicado: (2021)